AJP - Endo AJP: Cell Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 271: E434-E438, 1996;
0193-1849/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roussel, R.
Right arrow Articles by Bloch, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roussel, R.
Right arrow Articles by Bloch, G.

AJP - Endocrinology and Metabolism, Vol 271, Issue 3 E434-E438, Copyright © 1996 by American Physiological Society

ARTICLES

In vivo NMR evidence for moderate glucose accumulation in human skeletal muscle during hyperglycemia

R. Roussel, G. Velho, P. G. Carlier, L. Jouvensal and G. Bloch
Service Hospitalier Frederic Joliot, Departement de Recherche Medicale, Orsay, France.

Although the absence of intracellular (IC) free glucose is direct evidence of glucose transport being the rate-limiting step for muscle glucose disposal at euglycemia, the scarcity of data in humans during hyperglycemia precludes any definitive conclusion. In the present study, 13C and 31P in vivo nuclear magnetic resonance (NMR) data from two separate groups of subjects were combined to measure IC free glucose in the human skeletal muscle. When these noninvasive tools were used with an infusion of [1-13C]glucose, a steady-state concentration of 1.2 +/- 0.2 mmol IC glucose/l IC water was observed at the end of a 2-h hyperglycemic clamp with somatostatin infusion, during which glycemia was maintained at approximately 22 mmol/l and insulinemia at approximately 5 mU/l. Despite this moderate glucose accumulation, the persistence of a large transmembrane glucose gradient suggests that the posttransport steps do not play a significant role in the control of muscle glucose disposal in these specific conditions, relevant to insulinopenic diabetic patients.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. R. Chase, D. L. Rothman, and R. G. Shulman
Flux control in the rat gastrocnemius glycogen synthesis pathway by in vivo 13C/31P NMR spectroscopy
Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E598 - E607.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. E. Halseth, D. P. Bracy, and D. H. Wasserman
Overexpression of hexokinase II increases insulinand exercise-stimulated muscle glucose uptake in vivo
Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E70 - E77.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. E. Halseth, D. P. Bracy, and D. H. Wasserman
Limitations to exercise- and maximal insulin-stimulated muscle glucose uptake
J Appl Physiol, December 1, 1998; 85(6): 2305 - 2313.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
R. Roussel, P. G. Carlier, J.-J. Robert, G. Velho, and G. Bloch
13C/31P NMR studies of glucose transport in human skeletal muscle
PNAS, February 3, 1998; 95(3): 1313 - 1318.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. W. Cline, B. M. Jucker, Z. Trajanoski, A. J. M. Rennings, and G. I. Shulman
A novel 13C NMR method to assess intracellular glucose concentration in muscle, in vivo
Am J Physiol Endocrinol Metab, February 1, 1998; 274(2): E381 - E389.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online